These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10466430)
41. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters. Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233 [TBL] [Abstract][Full Text] [Related]
42. ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis. Tisserand P; Fouquet C; Marck V; Mallard C; Fabre M; Vielh P; Soussi T Cancer; 2003 Aug; 99(4):223-32. PubMed ID: 12925984 [TBL] [Abstract][Full Text] [Related]
43. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312 [TBL] [Abstract][Full Text] [Related]
44. A double germline mutations in the APC and p53 genes. Zajac V; Tomka M; Ilenciková D; Májek P; Stevurková V; Kirchhoff T Neoplasma; 2000; 47(6):335-41. PubMed ID: 11263856 [TBL] [Abstract][Full Text] [Related]
45. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells. Ridgeway AG; McMenamin J; Leder P Oncogene; 2006 Jun; 25(25):3518-27. PubMed ID: 16434961 [TBL] [Abstract][Full Text] [Related]
46. UV-induced mutagenesis of human p53: analysis using a double-selection method in yeast. Moshinsky DJ; Wogan GN Environ Mol Mutagen; 2000; 35(1):31-8. PubMed ID: 10692225 [TBL] [Abstract][Full Text] [Related]
47. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Tomkova K; Tomka M; Zajac V Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649 [TBL] [Abstract][Full Text] [Related]
48. A functional screen for germ line p53 mutations based on transcriptional activation. Frebourg T; Barbier N; Kassel J; Ng YS; Romero P; Friend SH Cancer Res; 1992 Dec; 52(24):6976-8. PubMed ID: 1458490 [TBL] [Abstract][Full Text] [Related]
49. Database of p53 gene somatic mutations in human tumors and cell lines. Hollstein M; Rice K; Greenblatt MS; Soussi T; Fuchs R; Sørlie T; Hovig E; Smith-Sørensen B; Montesano R; Harris CC Nucleic Acids Res; 1994 Sep; 22(17):3551-5. PubMed ID: 7937055 [TBL] [Abstract][Full Text] [Related]
50. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hernandez-Boussard T; Rodriguez-Tome P; Montesano R; Hainaut P Hum Mutat; 1999; 14(1):1-8. PubMed ID: 10447253 [TBL] [Abstract][Full Text] [Related]
51. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Inga A; Iannone R; Monti P; Molina F; Bolognesi M; Abbondandolo A; Iggo R; Fronza G Oncogene; 1997 Mar; 14(11):1307-13. PubMed ID: 9178891 [TBL] [Abstract][Full Text] [Related]
52. Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast. Smardová J; Pavlová S; Koukalová H Pathol Oncol Res; 2002; 8(4):245-51. PubMed ID: 12579210 [TBL] [Abstract][Full Text] [Related]
53. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay. Tada M; Iggo RD; Ishii N; Shinohe Y; Sakuma S; Estreicher A; Sawamura Y; Abe H Int J Cancer; 1996 Jul; 67(3):447-50. PubMed ID: 8707423 [TBL] [Abstract][Full Text] [Related]
54. Loss of p53 transcriptional activity in hepatocellular carcinoma evaluated by yeast-based functional assay: comparison with p53 immunohistochemistry. Mitsumoto Y; Nakajima T; Marutani M; Kashiwazaki H; Moriguchi M; Kimura H; Okanoue T; Kagawa K; Tada M Hum Pathol; 2004 Mar; 35(3):350-6. PubMed ID: 15017592 [TBL] [Abstract][Full Text] [Related]
55. Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Concin N; Zeillinger C; Tong D; Stimpfl M; König M; Printz D; Stonek F; Schneeberger C; Hefler L; Kainz C; Leodolter S; Haas OA; Zeillinger R Breast Cancer Res Treat; 2003 May; 79(1):37-46. PubMed ID: 12779080 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of heavy metal toxicity in eukaryotes using a simple functional assay. Riger CJ; Fernandes PN; Vilela LF; Mielniczki-Pereira AA; Bonatto D; Henriques JA; Eleutherio EC Metallomics; 2011 Dec; 3(12):1355-61. PubMed ID: 21879111 [TBL] [Abstract][Full Text] [Related]
57. Rare somatic p53 mutation identified in breast cancer: a case report. Smardová J; Nemajerová A; Trbusek M; Vagunda V; Kovarík J Tumour Biol; 2001; 22(2):59-66. PubMed ID: 11125276 [TBL] [Abstract][Full Text] [Related]
58. A simple p53 functional assay for screening cell lines, blood, and tumors. Flaman JM; Frebourg T; Moreau V; Charbonnier F; Martin C; Chappuis P; Sappino AP; Limacher IM; Bron L; Benhattar J Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3963-7. PubMed ID: 7732013 [TBL] [Abstract][Full Text] [Related]